AAAAAA

   
Results: 1-8 |
Results: 8
GABAPENTIN BIOAVAILABILITY - EFFECT OF DOSE AND FREQUENCY OF ADMINISTRATION IN ADULT PATIENTS WITH EPILEPSY
Authors: GIDAL BE DECERCE J BOCKBRADER HN GONZALEZ J KRUGER S PITTERLE ME RUTECKI P RAMSAY RE
Citation: Be. Gidal et al., GABAPENTIN BIOAVAILABILITY - EFFECT OF DOSE AND FREQUENCY OF ADMINISTRATION IN ADULT PATIENTS WITH EPILEPSY, Epilepsy research, 31(2), 1998, pp. 91-99
CONTRASTING NUTRIENT EFFECTS ON THE PLASMA-LEVELS OF AN AMINO ACID-LIKE ANTIEPILEPTIC AGENT FROM JEJUNAL ADMINISTRATION IN DOGS
Authors: STEVENSON CM RADULOVIC LL BOCKBRADER HN FLEISHER D
Citation: Cm. Stevenson et al., CONTRASTING NUTRIENT EFFECTS ON THE PLASMA-LEVELS OF AN AMINO ACID-LIKE ANTIEPILEPTIC AGENT FROM JEJUNAL ADMINISTRATION IN DOGS, Journal of pharmaceutical sciences, 86(8), 1997, pp. 953-957
DISPOSITION OF GABAPENTIN IN ANURIC SUBJECTS ON HEMODIALYSIS
Authors: WONG MO ELDON MA KEANE WF TURCK D BOCKBRADER HN UNDERWOOD BA SEDMAN AJ HALSTENSON CE
Citation: Mo. Wong et al., DISPOSITION OF GABAPENTIN IN ANURIC SUBJECTS ON HEMODIALYSIS, Journal of clinical pharmacology, 35(6), 1995, pp. 622-626
DISPOSITION OF GABAPENTIN (NEURONTIN) IN MICE, RATS, DOGS, AND MONKEYS
Authors: RADULOVIC LL TURCK D VONHODENBERG A VOLLMER KO MCNALLY WP DEHART PD HANSON BJ BOCKBRADER HN CHANG T
Citation: Ll. Radulovic et al., DISPOSITION OF GABAPENTIN (NEURONTIN) IN MICE, RATS, DOGS, AND MONKEYS, Drug metabolism and disposition, 23(4), 1995, pp. 441-448
LACK OF INTERACTION OF GABAPENTIN WITH CARBAMAZEPINE OR VALPROATE (VOL 35, PG 155, 1994)
Authors: RADULOVIC LL WILDER BJ LEPPIK IE BOCKBRADER HN CHANG T POSVAR EL SEDMAN AJ UTHMAN BM ERDMAN GR
Citation: Ll. Radulovic et al., LACK OF INTERACTION OF GABAPENTIN WITH CARBAMAZEPINE OR VALPROATE (VOL 35, PG 155, 1994), Epilepsia, 35(3), 1994, pp. 707-707
LACK OF INTERACTION OF GABAPENTIN WITH CARBAMAZEPINE OR VALPROATE
Authors: RADULOVIC LL WILDER BJ LEPPIK IE BOCKBRADER HN CHANG T POSVAR EL SEDMAN AJ UTHMAN BM ERDMAN GR
Citation: Ll. Radulovic et al., LACK OF INTERACTION OF GABAPENTIN WITH CARBAMAZEPINE OR VALPROATE, Epilepsia, 35(1), 1994, pp. 155-161
PHARMACOKINETICS, MASS-BALANCE, AND INDUCTION POTENTIAL OF A NOVEL GABA UPTAKE INHIBITOR, CI-966 HCL, IN LABORATORY-ANIMALS
Authors: RADULOVIC LL BOCKBRADER HN CHANG T
Citation: Ll. Radulovic et al., PHARMACOKINETICS, MASS-BALANCE, AND INDUCTION POTENTIAL OF A NOVEL GABA UPTAKE INHIBITOR, CI-966 HCL, IN LABORATORY-ANIMALS, Pharmaceutical research, 10(10), 1993, pp. 1442-1445
MEASUREMENT OF CI-979 (A CANDIDATE DRUG FOR THE TREATMENT OF AGE-RELATED DISORDERS OF COGNITION) IN HUMAN PLASMA BY CAPILLARY GAS-CHROMATOGRAPHY WITH NITROGEN-SELECTIVE DETECTION
Authors: WINDSOR BL RADULOVIC LL BOCKBRADER HN CHANG T
Citation: Bl. Windsor et al., MEASUREMENT OF CI-979 (A CANDIDATE DRUG FOR THE TREATMENT OF AGE-RELATED DISORDERS OF COGNITION) IN HUMAN PLASMA BY CAPILLARY GAS-CHROMATOGRAPHY WITH NITROGEN-SELECTIVE DETECTION, Journal of chromatography. Biomedical applications, 619(2), 1993, pp. 315-318
Risultati: 1-8 |